Mustang BIO, Inc. insider trading
Every open-market purchase and sale by Mustang BIO, Inc.'s officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
Insider purchases, 5 years $237 1 trade by 1 insider
3 months later: median −23.4% (−18.3% vs S&P 500) Insider sales, 5 years $241 2 trades by 2 insiders
3 months later: median −23.4% (−18.3% vs S&P 500)
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Mustang BIO, Inc.’s insiders pay?
From November 5, 2018 to November 8, 2021, 3 insiders reported 10 open-market purchases and 3 sales not made under a pre-set plan in Mustang BIO, Inc.
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Litchman Manuel Md | President and CEO | 7 | — | — | 1 | — | November 8, 2021 |
| Achenbach Brian | SVP, Fin. & Corp. Controller | 1 | — | — | 2 | — | October 21, 2021 |
| Rosenwald Lindsay A Md | Director | 2 | — | — | 0 | — | December 15, 2020 |